Institut Pasteur
Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment
Quotient’s somatic genomics platform technology will be used to develop the treatment
Abivax shares positive late-stage results for obefazimod in ulcerative colitis
Inflammatory bowel disease affects nearly one in every 100 people in the US
FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
Non-muscle-invasive bladder cancer represents around 75% of all new bladder cancer cases
Dovetail wins Communiqué Agility and Flexibility award at Communiqué 2021
This inaugural award was given to Dovetail amid fierce competition from four other agencies
Gut instincts lead Takeda to GI pipeline success
Takeda’s Asit Parikh talks about a game changer for IBD patients and the company’s long-term strategy for gene and cell therapy
Pfizer’s Xeljanz picks up a third indication in the US
The JAK inhibitor can now treat patients with ulcerative colitis
Gilead and Verily team up to map inflammatory diseases
Computational analysis could provide deeper understanding of disease
Joined-up thinking on anaemia
Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’s quality of life, but it’s often under-treated.
Pharma and NHS working together for patients – the IBD Registry Industry Working Group
We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to...
Ferring agrees Chinese reproductive medicine research deal
Work with the Chinese Academy of Sciences on the long-term project
Takeda unveil final chapters of first graphic novel The Unbeatables
Partners with Marvel to complete the graphic novel as a part of its IBD Unmasked initiative
Takeda and Marvel extend IBD cartoon initiative
Next chapter of IBD Unmasked released to celebrate World IBD Day